Navigation Links
Dynamics in Medical Technology

Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session

... ORLANDO, Fla., March 29 /PRNewswire/ -- Impulse dynamics (U.S.A.) Inc. announced today findings from the ... initiating a new contraction. About Impulse dynamics Impulse dynamics is focused on the development of electrical ...

New Study Shows Cloning from Dried Cells Now Possible

... MT. LAUREL, N.J., Sept. 8 /PRNewswire/ -- Core dynamics Inc. today announced that cloning with ... for clinical use." About Core Dynamics: Core dynamics is a privately held biotechnology company that ... are located in Mt. Laurel, New Jersey. Core dynamics hopes to develop additional applications through ...

New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials

... Ariz., April 28 /PRNewswire/ -- General dynamics Viz, a part of General dynamics C4 Systems, introduces CoMotion(R) Trials, ... product management director for General dynamics Viz. "CoMotion Trials streamlines the flow of ...

Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer

... USA: Robert D. Stanislaro Evan Smith Financial dynamics Financial dynamics T: 212-850-5657 T: 212-850-5606 E: ...

Progen Announces PI-88 Phase 2 Lung Cancer Results

... Media Relations USA: Robert D. Stanislaro Financial dynamics T: 212-850-5657 E: robert.stanislaro@fd.com Investor Relations USA: Evan Smith Financial dynamics T: 212-850-5606 E: evan.smith@fd.com ...

Hand Washing with 4% CHG Antiseptic Kills Flu Viruses

... and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. ...

USAID Provides $5M in Emergency Support as Swine Flu Spreads

... Control and Prevention, to work with authorities in Mexico. The team will further investigate and characterize the virulence and transmission dynamics of the disease. USAID is responding to the international outbreak in coordination with the Centers for Disease Control and Prevention (CDC). To ...

First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008

... impact of climate change on major flooding in Europe (Institute for Meteorology in Berlin) Project dedicated to the study of the impact and dynamics of marine aliens in the context of climate change (Queen's University Belfast) Project dedicated to assessing civil conflict risks ...

A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe

... DecisionBase 2009 is a decision-support tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development. The report can be purchased by contacting Decision Resources. ...

Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI

... DecisionBase 2009 is a decision-support tool that provides in-depth analysis of unmet need, physician expectations of new therapies and commercial dynamics to help pharmaceutical companies optimize their investments in drug development. The report can be purchased by contacting Decision Resources. ...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

... on condoms or abstinence as methods for protecting themselves from HIV. Even a partially effective microbicide could have a profound impact on the dynamics of HIV transmission. According to mathematical modeling conducted by the London School of Hygiene and Tropical Medicine, 2.5 million HIV infections ...

Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline

... Enquiries Biotica Technology Ltd Tel: +44-1799-532920 Dr Edward E. Hodgkin, CEO enquiries@biotica.com Financial dynamics Tel: +44(0)20-7831-3113 Ben Atwell Ben.Atwell@fd.com ...

Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand

... Isogen can ramp follow-on funding to expand its presence in the biopharma industry. "Isogen will help our customers address major industry dynamics that are reshaping the face and complexity of sterile clinical trials materials supply," said Edwards. "Regulators in the U.S. and Europe ...

Elsevier is Expanding eClinical Solutions in Europe

... throughout their workday." Capturing 'e' Opportunities Elsevier is uniquely positioned to replicate its success in the U.S. abroad. Market dynamics are different, as European E-Health markets and Elsevier's positions within them are at an earlier stage of development than in the U.S. However, key ...

GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer

... in terms of gain and loss of functions. We need to understand in a database structure the causal relationships between the involved pathways and the dynamics of pathway activation during tumorigenesis. These are two main goals of the MetaMiner project." "There are many 'generic' pathway tools on the ...

Discovering How Video Games Can Motivate Healthy Behaviors: More than $2 Million Awarded to 12 Research Teams Across U.S.

... time, players' amount, type and enjoyment of physical activity, quality of life, body mass index and body composition. It also will examine family dynamics in the activities they do together and factors that influence their motivation to be physically active. Union College, Department of Psychology ...

Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting

... Executive Vice President. "These Velos customers have the knowledge, resources, and incentive to facilitate positive change. We've witnessed these dynamics in action this week here in San Francisco." About Velos Velos is the trusted clinical trial management resource for investigators, sponsors and ...

Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results

... to joining Neurocrine, Mr. Beck held financial management positions at various high technology and financial services companies, including General dynamics and Ernst and Young LLP. Mr. Beck received a B.A. in accounting from the University of Washington and also holds a Th.B. in theology from a Seattle, ...

Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting

... Dr. Poland's presentation, entitled "Using in Vitro and Literature Data to Predict Effects of New Anti-Retrovirals", will describe how PK/PD-viral dynamics models developed using preclinical data and literature data on existing HIV treatments can inform dose-response predictions for new anti-retroviral ...

Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid

... U.S. Investor and Media Contacts: Harry Rosen Brian Ritchie Phosphagenics Limited Financial dynamics President and CEO Tel +1 212 850 5683 Tel +61 3 9605 5900 Mary McSwiggan Phosphagenics Limited Investor Relations Manager ...

West Pharmaceutical Services, Inc. Appoints New Director

... Japan, Asia and Australia. Contacts: Investors and Financial Media: West Pharmaceutical Services, Inc. Financial dynamics Michael A. Anderson Evan Smith/Theresa Kelleher Vice President and Treasurer (212) 850-5600 (610) 594-3345 ...

KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model

... of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease). KM-801 is a small-molecule agent, which has been shown to alter microtubule dynamics in nerve cells in preclinical studies (J Biol Chem. 2007 Jun 13). KineMed researchers have discovered that patients with ALS have more rapid rates ...

Molnlycke Drives 'Home' the Fight Against Staph and Other MRSA Infections

... and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. (1) Bell, Edward A. "Antibiotic Choices for ...

New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace

... First comprehensive study of market dynamics offers insights into what will be needed to get ... results from the first comprehensive study of the dynamics of the global TB drug market that offers a ... The study, Pathway to Patients: Charting the dynamics of the Global TB Drug Market, reveals the ...

CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

... of our three lead compounds, yet clinical and preclinical data for these product candidates demonstrate that subtle differences in microtubule dynamics can lead to different approaches to the treatment of cancer. Panzem(R), MKC-1 and ENMD-1198 are all orally-active yet distinct tubulin ...

CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting

... as peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells. Mitotic kinesins ...

Vertex Pharmaceuticals Announces New Data for Investigational HCV Protease Inhibitor Telaprevir to be Presented at 42nd Annual Meeting of the European Association for the Study of the Liver (EASL)

... Viral Decline During Telaprevir (VX-950) and Peg-IFN Combination Treatment Predicted by a New Combined Intracellular and Cellular Hepatitis C Viral dynamics Model," will be presented by A.U. Neumann of Bar-llan University, Israel. -- "Telaprevir (VX-950)-Resistant Variants Exhibit Reduced Replication ...

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

... tubulin protein, either in the monomer form or polymerized in microtubules, and prevent cancer cell proliferation by interfering with the microtubule dynamics required for cell division. This interference blocks the cell cycle sequence, leading to cell death (apoptosis). About EntreMed EntreMed, Inc. is ...

Telomerase Presentations at the AACR 2007 Annual Meeting

... to form aggressive tumors. Information in Dr. DePinho's talk and other presentations throughout the AACR meeting on the regulation of telomere dynamics and telomerase activity elucidates the potential for telomerase-inhibiting molecules in the treatment of cancer. Cancer Stem Cells Cancer stem ...

Independent publication supports the profile of CeNeS phase II compound, CNS 5161

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

FDA approves IND on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...

Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

... peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells. Mitotic kinesins ...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...
Other Contents
(Date:7/11/2014)... that under the normal circumstances, astrocytes participate ... neuronal environment, and exhibit therapeutic and repairing ... Previous studies have found that nerve cells ... induction have reduced viability, which produces influences ... Yuan, Kailuan General Hospital, Hebei United University, ...
(Date:7/11/2014)... Rio de Janeiro, Brazil- In the brains of ... mechanism that allows an electric or chemical signal ... another. Chemical synapses, which are the most abundant ... inhibitory. Synapse formation is crucial for learning, memory, ... and inhibitory synapses critical for brain function. ...
(Date:7/10/2014)...  Aware, Inc. (NASDAQ: AWRE ), a ... on June 26, 2014 that its Board of Directors ... share, or approximately $40 million in total.  The Board ... a payment date of July 24, 2014.  The Company ... an ex-dividend date for this special cash dividend.  An ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2
(Date:7/12/2014)... “After my mom’s stroke, she loss the use ... loss the use of his left side. Eating became a difficult ... help people like them enjoy eating again,” said an inventor, from ... PATRICIA CAROL HALL PLATE (P C H PLATE). , The PATRICIA ... way to eat for individuals who suffer from stroke, experience tremors ...
(Date:7/12/2014)... With prom shopping reaching its final days, VogueQueen.com, a ... showcase its new and trendy apparels. Recently, the company ... its online shop. Additionally, it is now providing huge ... According to the company’s sales manager, the promotion will ... , He says, “Now, worldwide clients can order cheap ...
(Date:7/12/2014)... 2014 “Critical Care Therapeutics in ... Late-Stage Four-Factor PCCs and Recombinant Products to Drive ... care market in the US, UK, France, Germany, ... an estimation of market size for 2013, along ... care indications that are being treated using the ...
(Date:7/12/2014)... 2014 Utah Valley Entrepreneurial Forum Top ... awards being bestowed to companies in revenue, and pre-revenue ... community with recognition for new ideas as well as ... revenue. , 25 Under 5 highlights outstanding Utah entrepreneurs ... under 5 years old. Award recipients were recognized at ...
(Date:7/12/2014)... 12, 2014 Praeclarus Press ... as a valuable new resource for women in need ... American women work away from their children. Today’s mothers ... benefits of breastfeeding, but often feel unsupported when it ... babies. With its evidence-based insights, and written by Nancy ...
Breaking Medicine News(10 mins):Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2
Other TagsOther Tags